Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Xerencia de Xestión Integrada de Ferrol
With
University Hospital Complex of Santiago de Compostela
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Data will be collected for all patients with pseudoexfoliation glaucoma (PXFG), ocular hypertension (OHT) and pseudoexfoliation syndrome, POAG and other secondary open angle glaucoma (OAG) diagnosed, who underwent surgery from 2018 to 2022.
Patients should be candidates for filtering glaucoma surgery for the following indications:
uncontrolled intraocular pressure (IOP)
intolerance or non-adherence to topical treatment
glaucoma progression despite topical therapy
surgical cataract patients undergoing phacoemulsification, who were treated with two or more hypotensive drugs and wished to withdraw the medication due to side effects and/or discomfort of the treatment.
Refractory glaucoma and eyes with previous filtering surgery, previous laser treatments or micropulse transscleral cyclophotocoagulation will be also included.
You may not be if
Patients with follow up less than 12 months.
Patients with end-stage glaucoma, uveitic and angle closure glaucoma.
